131 related articles for article (PubMed ID: 34224989)
1. Upregulation of fibroblast growth factor 2 contributes to endometriosis through SPRYs/DUSP6/ERK signaling pathway.
Yu X; Wang Y; Tan X; Li M
Acta Histochem; 2021 Jul; 123(5):151749. PubMed ID: 34224989
[TBL] [Abstract][Full Text] [Related]
2. Effect of FGF2 on the activity of SPRYs/DUSP6/ERK signaling pathway in endometrial glandular epithelial cells of endometriosis.
Yu XY; Wang XT; Chu YL; Qu HM; Liu J; Zhang YH; Li MJ
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1554-1568. PubMed ID: 29630097
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 2 promotes the proliferation, migration, and invasion of ectopic stromal cells via activation of extracellular-signal-regulated kinase signaling pathway in endometriosis.
Xu Y; Gao F; Zhang J; Cai P; Xu D
Bioengineered; 2022 Apr; 13(4):8360-8371. PubMed ID: 35311468
[TBL] [Abstract][Full Text] [Related]
4. TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6.
Wu YT; Ma SY; Sun WQ; Shen WW; Zhu HT; Zhang Q; Chen HF
J Clin Endocrinol Metab; 2021 Jan; 106(2):526-538. PubMed ID: 33146694
[TBL] [Abstract][Full Text] [Related]
5. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway.
Chen Q; Hang Y; Zhang T; Tan L; Li S; Jin Y
Am J Physiol Cell Physiol; 2018 Dec; 315(6):C863-C872. PubMed ID: 30281322
[TBL] [Abstract][Full Text] [Related]
6. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.
Fan MJ; Liang SM; He PJ; Zhao XB; Li MJ; Geng F
Radiol Oncol; 2019 Sep; 53(3):307-315. PubMed ID: 31553703
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
Zhang H; Guo Q; Wang C; Yan L; Fu Y; Fan M; Zhao X; Li M
Mol Cell Endocrinol; 2013 Aug; 376(1-2):60-9. PubMed ID: 23419500
[TBL] [Abstract][Full Text] [Related]
8. Loss of expressions of Dusp6, Sprouty4, and Sef, negative regulators of FGF2/ERK1/2 signaling, in the endometrium of women with adenomyosis.
Guo Q; Zhang H; Zhao X; Fu Y; Zhang J; Li M
Int J Gynecol Pathol; 2014 May; 33(3):288-97. PubMed ID: 24681741
[TBL] [Abstract][Full Text] [Related]
9. Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.
Zhang Z; Kobayashi S; Borczuk AC; Leidner RS; Laframboise T; Levine AD; Halmos B
Carcinogenesis; 2010 Apr; 31(4):577-86. PubMed ID: 20097731
[TBL] [Abstract][Full Text] [Related]
10. Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia.
Bermudez O; Jouandin P; Rottier J; Bourcier C; Pagès G; Gimond C
J Cell Physiol; 2011 Jan; 226(1):276-84. PubMed ID: 20665674
[TBL] [Abstract][Full Text] [Related]
11. Infrequent methylation of the DUSP6 phosphatase in endometrial cancer.
Chiappinelli KB; Rimel BJ; Massad LS; Goodfellow PJ
Gynecol Oncol; 2010 Oct; 119(1):146-50. PubMed ID: 20638106
[TBL] [Abstract][Full Text] [Related]
12. Effects of lncRNA BANCR on endometriosis through ERK/MAPK pathway.
Zhu MB; Chen LP; Hu M; Shi Z; Liu YN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6806-6812. PubMed ID: 31486479
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells.
Lin SC; Wang CC; Wu MH; Yang SH; Li YH; Tsai SJ
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1515-23. PubMed ID: 22648654
[TBL] [Abstract][Full Text] [Related]
14. Spry1 and Spry2 are necessary for eyelid closure.
Kuracha MR; Siefker E; Licht JD; Govindarajan V
Dev Biol; 2013 Nov; 383(2):227-38. PubMed ID: 24055172
[TBL] [Abstract][Full Text] [Related]
15. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
16. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.
Matsuzaki S; Darcha C
Hum Reprod; 2015 Jul; 30(7):1606-16. PubMed ID: 25976656
[TBL] [Abstract][Full Text] [Related]
17. NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity.
Ingram K; Samson SC; Zewdu R; Zitnay RG; Snyder EL; Mendoza MC
Oncogene; 2022 Jan; 41(2):293-300. PubMed ID: 34689179
[TBL] [Abstract][Full Text] [Related]
18. F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.
Sales KJ; Boddy SC; Williams AR; Anderson RA; Jabbour HN
Endocrinology; 2007 Aug; 148(8):3635-44. PubMed ID: 17478553
[TBL] [Abstract][Full Text] [Related]
19. Leptin receptor is induced in endometriosis and leptin stimulates the growth of endometriotic epithelial cells through the JAK2/STAT3 and ERK pathways.
Oh HK; Choi YS; Yang YI; Kim JH; Leung PC; Choi JH
Mol Hum Reprod; 2013 Mar; 19(3):160-8. PubMed ID: 23184927
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of dual-specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA-28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2.
Kanda Y; Mizuno A; Takasaki T; Satoh R; Hagihara K; Masuko T; Endo Y; Tanabe G; Sugiura R
Genes Cells; 2021 Feb; 26(2):109-116. PubMed ID: 33249692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
